Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecast to 2025
[194 Pages Report]The pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. Growth in this market is driven by the versatility and unique functional properties of gelatin in pharmaceutical applications, the increasing demand for gelatin capsules due to rise in chronic illnesses, and the increase in ageing population globally.
To know about the assumptions considered for the study, Request for Free Sample Report
Covid-19 Impact on the Pharmaceutical Gelatin Market
The rising prevalence of COVID-19 has driven the demand for pharmaceutical industry across the globe. However, the quarantine and lockdown measures imposed in various regions has resulted in transport and logistics issues, causing difficulty in procurement of raw material for pharmaceutical gelatin. This has affected the supply of pharmaceutical gelatin in some regions, resulting in a supply-demand gap. Countries with prolonged periods of lockdown such as India and China have been affected more severely than others, such as, US and countries of the European Union. However, this effect is expected to be temporary and would recover in the post-Covid 19 period as normal operations are reinstated.
Pharmaceutical Gelatin Market Dynamics
Driver: Versatility and superiority of gelatin in pharmaceutical applications
The unique functional capabilities of gelatin such as gelling, adhesion, coating, binding, and film-building makes it highly advantageous for use in the pharmaceutical industry. Gelatin coating on hard capsules, softgel capsules, and tablets not only masks the odor of medicines but also facilitates ease in swallowing. Moreover, the properties of gelatin provide protection against environmental changes associated with oxygen or moisture, thereby increasing the shelf-life of these products. These superior functional properties of gelatin are a driver for the pharmaceutical gelatin market.
Restraint: Increasing popularity of veganism
In recent years, there has been a rising trend in veganism across the world, which is defined as the abstinence from animal-based products. These trends have also extended to the pharmaceutical industry, with capsule manufacturers offering non-gelatin capsules or vegetarian capsules manufactured from purely plant-derived materials to meet the demands of consumers. The increasing demand for plant-based pharmaceutical products and subsequent changes in their product portfolios by capsule manufacturers are expected to restrain the growth of pharmaceutical gelatin during the forecast period.
Opportunity: Rising demand for pharmaceutical-grade gelatin in emerging countries
Emerging economies such as the Asia Pacific, the Middle East, Latin America, and Africa provide significant opportunities for the growth of the market. Global raw gelatin and gelatin capsule manufacturers have been capitalizing on this demand by expanding their business presence and production capacities in these regions. The increasing demand in emerging economies, coupled with lower raw material and labor costs offer an opportunity for the growth of the market during the forecast period.
Challenge: Rising prices and poor availability of raw materials
One of the major challenges facing the global pharmaceutical gelatin market is the procurement of raw material. The main factor affecting the availability of raw materials for the extraction of gelatin is the functional capacity of slaughterhouses and the meat processing industry which varies significantly depending on economic conditions. Moreover, the handling of raw material and production are also governed by strict regulations in various countries to ensure the prevention of the spread of animal-borne diseases. This can can further affect supply in cases of export or import bans or in cases of incidences of these diseases in certain regions at any given time. These factors pose a significant challenge to the growth of the market during the forecast period.
The softgel capsules segment is expected to show the highest growth rate in the pharmaceutical gelatin market, by application, in the forecast period
Based on application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable Hemostats, and other applications. The high growth rate of softgel capsules is due to its advantages of being a patient-friendly dosage form due to the capability of being formulated appropriately for rapid or slow release, and high degree of reproducibility. These factors are responsible for the high growth rate of the softgel capsules in the application segment of the pharmaceutical gelatin market in the forecast period.
In the by source segment, porcine source holds the highest share in the pharmaceutical gelatin market in the forecast period
Based on source, the pharmaceutical gelatin market is segmented into porcine, bovine bone, bovine skin, marine & poultry. The porcine segment is estimated to grow at the highest growth during the forecast period. Factors such as its variety of applications in pharmaceutical industry, absorbable hemostats and other biomedical applications, along with lower cost of production and shorter manufacturing cycle are driving the growth of this segment.
The function of gelatin as a thickening agent is growing at the highest rate in the pharmaceutical gelatin market in the forecast period
Based on function, the pharmaceutical gelatin market is segmented into stabilizing agent, thickening agent, gelling agent & other functions. The thickening segment is estimated to grow at the highest growth due to its increasing scope due to its application in medicinal syrups, elixirs, and other liquid dosage forms. Moreover, gelatin is used to increase the viscosity of the dosage form without altering its other properties. The utility of gelatin as a thickening agent in antibiotic creams and lotions are also driving the growth of this segment.
Type B gelatin holds the highest market share in the pharmaceutical gelatin market in the forecast period
Based on type, the pharmaceutical gelatin market is segmented into Type A & Type B. The increasing preference for bovine bone for the manufacture of pharmaceutical gelatin and cultural acceptability of bovine source is driving the growth of the Type B segment in the pharmaceutical gelatin market can be attributed to the high share this segment in the forecast period.
The Asia Pacific region is expected to grow at the highest CAGR during the forecast period
The pharmaceutical gelatin market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. In this region, there is ample availability of porcine and bovine source of raw material, low cost of labor and capital investment, due to which major market players are investing in this region. These factors are driving the growth of the Asia Pacific region in the forecast period.
Key players in the pharmaceutical gelatin market:
The prominent players in the global pharmaceutical gelatin market include Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals. (US), India Gelatine & Chemicals Ltd. (India), Gelnex Industria E Comercio Ltda (Brazil), Junca Gelatines (Spain), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co. Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada).
Scope of the Report:
|
Report Metric |
Details |
|
Market Size available for years |
20182025 |
|
Base Year Considered |
2019 |
|
Forecast period |
2020-2025 |
|
Forecast Unit |
Value(USD) |
|
Segments covered |
Application, Source, Function, Type and Region |
|
Geographies covered |
North America Asia Pacific |
|
Companies Covered |
Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals. (US), India Gelatine & Chemicals Ltd. (India), Gelnex Industria E Comercio Ltda (Brazil), Junca Gelatines (Spain), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co. Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada). |
The research report categorizes the market into the following segments and subsegments:
Pharmaceutical Gelatin Market, By Application
- Hard Capsules
- Soft Capsules
- Tablets
- Absorbable Hemostats
- Other Applications
Pharmaceutical Gelatin Market, By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
Pharmaceutical Gelatin Market, by Function
- Stabilizing agents
- Thickening agents
- Gelling agents & Other Functions
Pharmaceutical Gelatin Market, by Type
- Type A
- Type B
Recent Developments
- In July 2020, Darling Ingredients, Inc. (US) launched X-Pure GelMA, the first Good Manufacturing Practice (GMP)-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications.
- In October 2019, Gelita AG (Germany) opened a modern gelatin production facility in Pingyang, China.
- In September 2019, Gelnex (Brazil) announced the planned construction of gelatin production facility in Paraguay and Indiana (US) to continue the expansion of its global presence.
- In December 2018, Gelnex (Brazil) proposed the construction of gelatin manufacturing plant in Portage (US) which would dry gelatin to a powder form for further use in pharmaceutical products.
- In November 2018, Darling Ingredients, Inc. (US) acquired the stock of PPH Conto Ltd.(Poland), a food-grade animal fat processing facility to enlarge production portfolio with high end food grade fats.
Frequently Asked Questions (FAQ):
Which are the top industry players in the global pharmaceutical gelatin market?
The top market players in the pharmaceutical gelatin market include Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals. (US), India Gelatine & Chemicals Ltd. (India), Gelnex Industria E Comercio Ltda (Brazil), Junca Gelatines (Spain), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co. Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada).
Which are the segments have been included in this report?
This report has the following main segments:
- By Application
- By Source
- By Function
- By Type
- By Region
Which geographical region is dominating in the pharmaceutical gelatin market?
The global pharmaceutical gelatin market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2019, the North America region dominated the global pharmaceutical gelatin market. This growth can be attributed to the widespread adoption of gelatin in pharmaceutical applications and rising R&D investment by major market players.
Which is the leading segment in the pharmaceutical gelatin market, by application?
The hard capsules segment commanded the largest market share in 2019. The large share of this segment can be attributed to stability, safety and efficacy offered by gelatin in hard capsules. Morever gelatin in hard capsules facilitates rapid drug release, uniform mixing of drugs, and barrier to atmospheric oxygen (preventing oxidation of drug molecules). These factors contribute to the large share of hard capsules in the pharmaceutical gelatin market.
What is the current size of the global pharmaceutical gelatin solutions market?
The global pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 24)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE PHARMACEUTICAL GELATIN MARKET
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.4.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 27)
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.3 PRIMARY SOURCES
2.1.3.1 Key data from primary sources
2.1.3.2 Breakdown of Primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
FIGURE 5 SUPPLY SIDE ANALYSIS: PHARMACEUTICAL GELATIN MARKET (2019)
FIGURE 6 APPROACH 3: BASED ON SOURCE, BY REGION (2019)
FIGURE 7 APPROACH 4: BASED ON RAW MATERIAL UTILIZATION IN GELATIN EMPTY CAPSULES
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PHARMACEUTICAL GELATIN MARKET (2020-2025)
2.3 DATA TRIANGULATION APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 HEALTH ASSESSMENT
2.7 COVID-19 ECONOMIC ASSESSMENT
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 11 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 12 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE PHARMACEUTICAL GELATIN MARKET
3 EXECUTIVE SUMMARY (Page No. - 42)
FIGURE 13 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020 VS. 2025 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL GELATIN MARKET
4 PREMIUM INSIGHTS (Page No. - 45)
4.1 PHARMACEUTICAL GELATIN MARKET OVERVIEW
FIGURE 16 VERSATILITY OF GELATIN IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS DRIVING MARKET GROWTH
4.2 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 INDIA PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 REGIONAL MIX: PHARMACEUTICAL GELATIN MARKET (20202025)
FIGURE 18 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (20202025)
4.4 PHARMACEUTICAL GELATIN MARKET: DEVELOPED VS. EMERGING MARKETS, 2020 VS. 2025 (USD MILLION)
FIGURE 19 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING THE STUDY PERIOD
5 MARKET OVERVIEW (Page No. - 48)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 PHARMACEUTICAL GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Versatility and superiority of gelatin in pharmaceutical applications
FIGURE 21 MEAN PERCENTAGE OF RIBOFLAVIN RELEASED FROM GELATIN, HPMC (1ST GENERATION), AND PULLULAN CAPSULES IN 0.1 M HCL BUFFER
5.2.1.2 Gelatin is an all-natural product fulfilling pharmaceutical regulations
5.2.2 RESTRAINTS
5.2.2.1 Increasing popularity of veganism
FIGURE 22 UK: RISING TREND OF VEGANISM FROM 2014 TO 2019 (000)
5.2.2.2 Cultural restrictions limit the growth of pharmaceutical gelatin in certain regions
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for pharmaceutical-grade gelatin in emerging countries
5.2.3.2 Enhancements in the properties of gelatin broaden the scope of its pharmaceutical applications
5.2.4 CHALLENGES
5.2.4.1 Increasing incidences of animal-borne diseases
FIGURE 23 CHINA: PORK IMPORTS (2018-2020)
FIGURE 24 CHINA: PER CAPITA PORK AVAILABILITY PER PERSON (2018-2020)
5.2.4.2 Rising prices and poor availability of raw materials
5.3 PORTERS FIVE FORCES ANALYSIS
TABLE 1 PORTERS FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 COMPETITIVE RIVALRY
5.4 TRENDS IN AVERAGE SELLING PRICE
TABLE 2 AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN, BY REGION, 2019-2020
5.5 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: PHARMACEUTICAL GELATIN MARKET
5.5.1 SOURCING OF RAW MATERIAL
5.5.2 COLLECTION AND TRANSPORT OF RAW MATERIAL
5.5.3 RAW MATERIAL PREPARATION AND PROCESSING
5.5.4 GELATIN PRODUCTION
5.5.5 DISTRIBUTION TO END USERS
5.6 ECOSYSTEM MAP
FIGURE 26 ECOSYSTEM: PHARMACEUTICAL GELATIN MARKET
5.6.1 INTRODUCTION
5.6.2 FARMING INPUT
5.6.3 FARMING
5.6.4 SLAUGHTERING
5.6.5 MANUFACTURING
5.6.6 SUPPLIERS/DISTRIBUTORS
5.6.7 END-PRODUCT MANUFACTURERS
5.7 KEY MARKETS FOR IMPORT/EXPORT
5.7.1 US
5.7.2 CHINA
5.7.3 BRAZIL
TABLE 3 IMPORTS & EXPORTS OF GELATIN, BY COUNTRY: (2018/2019) UNITS 1,000 TONS
6 INDUSTRY INSIGHTS (Page No. - 62)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 PRODUCT INNOVATIONS OVERCOME CROSSLINKING OF GELATIN
6.2.2 INCREASING BIOMEDICAL APPLICATIONS OF GELATIN
6.2.3 INSIGHTS ON THE CONVERSION OF GELATIN TO COLLAGEN PEPTIDE AND PHARMACEUTICAL GELATIN
6.3 IMPACT OF THE COLLAGEN PEPTIDES MARKET ON PHARMACEUTICAL GELATIN
6.4 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET
6.5 REGULATORY ANALYSIS
7 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION (Page No. - 68)
7.1 INTRODUCTION
TABLE 4 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 20182025 (USD MILLION)
7.2 HARD CAPSULES
7.2.1 COST-EFFECTIVITY OF GELATIN HARD CAPSULES DRIVES THE GROWTH OF THIS SEGMENT
TABLE 5 TYPICAL HARD GELATIN CAPSULE COMPOSITION
TABLE 6 DIMENSIONS (IN MILLIMETERS) OF TWO-PIECE HARD CAPSULES
TABLE 7 HARD CAPSULES MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.3 SOFTGEL CAPSULES
7.3.1 RISING APPLICATIONS OF SOFTGEL CAPSULES INCREASE THEIR DEMAND IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 8 DIFFERENCES BETWEEN HARD CAPSULES AND SOFTGEL CAPSULES
TABLE 9 SOFTGEL CAPSULES MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.4 TABLETS
7.4.1 THE APPLICATION OF GELATIN IN TABLET BINDING AND COATING IS EXPECTED TO INCREASE DURING THE FORECAST PERIOD
TABLE 10 IN VITRO PROPERTIES OF TABLET WITH GELATIN AS BINDER (CONCENTRATIONS 2.0-8.0%)
TABLE 11 TABLETS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.5 ABSORBABLE HEMOSTATS
7.5.1 INCREASING APPLICATIONS OF GELATIN IN ABSORBABLE HEMOSTATS DUE TO BIOCOMPATIBILITY TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 12 ABSORBABLE HEMOSTATS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.6 OTHER APPLICATIONS
7.6.1 VERSATILITY OF GELATIN DUE TO ITS UNIQUE FUNCTIONAL PROPERTIES BOOSTS ITS SCOPE FOR APPLICATIONS ACROSS THE PHARMACEUTICAL INDUSTRY
TABLE 13 OTHER APPLICATIONS, BY COUNTRY, 20182025 (USD MILLION)
7.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY APPLICATION
8 PHARMACEUTICAL GELATIN MARKET, BY SOURCE (Page No. - 78)
8.1 INTRODUCTION
8.1.1 GELATIN: REGULATIONS IMPLEMENTED BY DIFFERENT REGIONS/COUNTRIES
TABLE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 20182025 (USD MILLION)
TABLE 15 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 20182025 (KT)
8.2 PORCINE
8.2.1 LOWER MANUFACTURING COSTS OF PORCINE RAW MATERIAL TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 16 US: PORK EXPORTS IN USD MILLION (2019)
TABLE 17 PORCINE MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 18 PORCINE MARKET, BY REGION, 20182025 (KT)
8.3 BOVINE SKIN
8.3.1 INCREASING AVAILABILITY OF BOVINE SKIN TO BOOST APPLICATION IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 19 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES (NUMBER OF PIECES)
TABLE 20 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES (VALUE IN USD THOUSAND)
TABLE 21 BOVINE SKIN MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 22 BOVINE SKIN MARKET, BY REGION, 20182025 (KT)
8.4 BOVINE BONE
8.4.1 RISING PREFERENCE FOR BOVINE BONE AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET DUE TO LOW BLOOM AND HIGH VISCOSITY
TABLE 23 BOVINE BONE MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 24 BOVINE BONE MARKET, BY REGION, 20182025 (KT)
8.5 MARINE
8.5.1 RISING INCIDENCE OF ZOONOTIC DISEASES IN CATTLE AND PIGS TO DRIVE THE GROWTH OF MARINE SOURCE IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 25 MARINE MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 26 MARINE MARKET, BY REGION, 20182025 (KT)
8.6 POULTRY
8.6.1 STEADY AVAILABILITY OF POULTRY AS RAW MATERIAL IS EXPECTED TO BOOST UTILITY AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 27 AMINO ACID COMPOSITION OF GELATIN FROM DIFFERENT SOURCES
TABLE 28 POULTRY MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 29 POULTRY MARKET, BY REGION, 20182025 (KT)
8.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY SOURCE
FIGURE 27 BEEF EXPORTS FROM BRAZIL (1,000 TONS)
9 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION (Page No. - 91)
9.1 INTRODUCTION
FIGURE 28 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
9.2 BLOOM VALUE
9.2.1 HIGH BLOOM
9.2.2 LOW BLOOM
TABLE 30 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 20182025 (USD MILLION)
9.3 STABILIZING AGENTS
9.3.1 THE HIGH SHARE OF GELATIN IN THIS SEGMENT CAN BE ATTRIBUTED TO UTILITY AS A STABILIZING AGENT FOR CAPSULES AND VACCINES
TABLE 31 STABILIZING AGENT MARKET, BY COUNTRY, 20182025 (USD MILLION)
9.4 THICKENING AGENTS
9.4.1 THE RISING USE OF SYRUPS AND LIQUID DOSAGE FORMS TO DRIVE THE GROWTH OF THIS FUNCTIONAL SEGMENT IN THE PHARMACEUTICAL GELATIN MARKET
FIGURE 29 VISCOSITY BEHAVIOR OF GELATIN AS A FUNCTION OF TEMPERATURE AT 60OC
TABLE 32 THICKENING AGENT MARKET, BY COUNTRY, 20182025 (USD MILLION)
9.5 GELLING AGENTS & OTHER FUNCTIONS
9.5.1 THE UNIQUE GELLING PROPERTY OF GELATIN FINDS A SIGNIFICANT NUMBER OF APPLICATIONS IN THE FORMATION OF SOFTGEL CAPSULES AND HEMOSTATS
TABLE 33 GELLING AGENTS & OTHER FUNCTIONS MARKET, BY COUNTRY, 20182025 (USD MILLION)
10 PHARMACEUTICAL GELATIN MARKET, BY TYPE (Page No. - 98)
10.1 INTRODUCTION
FIGURE 30 PRODUCTION PROCESS: TYPE A AND TYPE B GELATIN
TABLE 34 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: HARD CAPSULES
TABLE 35 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: SOFTGEL CAPSULES
TABLE 36 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: TABLET GELATIN
TABLE 37 PHARMACEUTICAL GELATIN MARKET, BY TYPE, 20182025 (USD MILLION)
10.2 TYPE B
10.2.1 THE RISING DEMAND FOR BOVINE SOURCE RAW MATERIAL PROJECTED TO DRIVE THE GROWTH OF TYPE B GELATIN DURING THE FORECAST PERIOD
TABLE 38 NUTRITIONAL COMPOSITION OF TYPE B GELATIN
TABLE 39 TYPE B GELATIN MARKET, BY COUNTRY, 20182025 (USD MILLION)
10.3 TYPE A
10.3.1 COST-EFFECTIVENESS OF PROCESSING TYPE A GELATIN IS FAVORING GROWTH IN THE MARKET
TABLE 40 NUTRITIONAL COMPOSITION OF TYPE A GELATIN
TABLE 41 TYPE A GELATIN MARKET, BY COUNTRY, 20182025 (USD MILLION)
11 PHARMACEUTICAL GELATIN MARKET, BY REGION (Page No. - 104)
11.1 INTRODUCTION
FIGURE 31 INDIA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD IN THE PHARMACEUTICAL GELATIN MARKET (IN TERMS OF VALUE)
TABLE 42 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 20182025 (USD MILLION)
TABLE 43 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2025 (KT)
11.2 NORTH AMERICA
11.2.1 THE LARGE MARKET SHARE OF THE NORTH AMERICAN REGION CAN BE ATTRIBUTED TO THE HIGH R&D INVESTMENTS
FIGURE 32 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 44 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 20182025 (USD MILLION)
TABLE 45 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 46 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 47 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 48 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.2.2 US
11.2.2.1 Rising concerns in arthritis and obesity to drive the gelatin market in the US
TABLE 49 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 50 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 51 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 52 US: PHARMACEUTICAL MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Rising domestic demand for pharmaceutical products to drive the growth of the pharmaceutical gelatin market
TABLE 53 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 54 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 55 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 56 CANADA: PHARMACEUTICAL MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.3 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN NORTH AMERICA
11.4 EUROPE
11.4.1 RELIABLE AVAILABILITY OF RAW MATERIAL AND RISING DEMAND FOR MEDICATION IS DRIVING THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET IN THE EUROPEAN REGION
FIGURE 33 EUROPE: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 57 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 20182025 (USD MILLION)
TABLE 58 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 59 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 60 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 61 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 20182025 (USD MILLION)
11.4.2 GERMANY
11.4.2.1 Growth of the pharmaceutical industry in Germany to drive the demand for gelatin
TABLE 62 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 63 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 64 GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 65 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 20182025 (USD MILLION)
11.4.3 FRANCE
11.4.3.1 High beef production in France to drive the pharmaceutical gelatin market
TABLE 66 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 67 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 68 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 69 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 20182025 (USD MILLION)
11.4.4 UK
11.4.4.1 Higher healthcare spending and medicine consumption fuels pharmaceutical gelatin market growth
TABLE 70 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 71 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 72 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 73 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 20182025 (USD MILLION)
11.4.5 ITALY
11.4.5.1 Growth of the pharmaceutical manufacturing industry to fuel the demand for gelatin
TABLE 74 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 75 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 76 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 77 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 20182025 (USD MILLION)
11.4.6 SPAIN
11.4.6.1 Abundance of porcine raw material to drive the market for gelatin in Spain
TABLE 78 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 79 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 80 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 81 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 20182025 (USD MILLION)
11.4.7 REST OF EUROPE
11.4.7.1 High consumption and production to drive the growth of the pharmaceutical gelatin market in Rest of Europe
TABLE 82 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 20182025 (USD MILLION)
TABLE 83 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 84 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 85 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 20182025 (USD MILLION)
11.5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN EUROPE
11.6 ASIA PACIFIC
11.6.1 INCREASE IN CHRONIC ILLNESSES AND DEMAND FOR MEDICATION BOOSTS THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET
FIGURE 34 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 86 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 20182025 (USD MILLION)
TABLE 87 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 88 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 89 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 90 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.6.2 CHINA
11.6.2.1 Chinas large population and rise in chronic diseases drive the market for gelatin
TABLE 91 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 92 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 93 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 94 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.6.3 JAPAN
11.6.3.1 Increasing aging population drives the market for pharmaceutical gelatin
TABLE 95 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 96 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 97 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 98 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.6.4 INDIA
11.6.4.1 The booming pharmaceutical industry in the country propels the growth of the pharmaceutical gelatin market
TABLE 99 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 100 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 101 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 102 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.6.5 REST OF ASIA PACIFIC
11.6.5.1 Australian and Vietnamese pharmaceutical industries drive the demand for pharmaceutical gelatin
TABLE 103 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 104 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 105 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 106 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE ASIA PACIFIC REGION
11.8 REST OF THE WORLD
TABLE 107 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION 20182025 (USD MILLION)
TABLE 108 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 109 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 110 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 111 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.8.1 LATIN AMERICA
11.8.1.1 High availability of raw material drives the growth of the pharmaceutical gelatin market in Latin America
TABLE 112 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 113 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 114 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 115 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.8.2 MIDDLE EAST & AFRICA
11.8.2.1 Rising popularity of halal gelatin drives the growth of the pharmaceutical gelatin market in the Middle East
TABLE 116 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 20182025 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 20182025 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 20182025 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 20182025 (USD MILLION)
11.9 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE REST OF THE WORLD
12 COMPETITIVE LANDSCAPE (Page No. - 149)
12.1 OVERVIEW
FIGURE 35 KEY DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL GELATIN MARKET, 20172020
FIGURE 36 MARKET EVALUATION FRAMEWORK: EXPANSIONS DOMINATED THE MARKET IN 2018 AND 2019
12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
12.3 PRODUCT BENCHMARKING
12.4 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHICAL ASSESSMENT
12.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 120 PRODUCT LAUNCHES (2018-2020)
TABLE 121 EXPANSIONS (20182019)
TABLE 122 ACQUISITIONS (2018)
TABLE 123 AGREEMENTS (2017)
TABLE 124 OTHER DEVELOPMENTS (2020)
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 156)
13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
13.2 PHARMACEUTICAL GELATIN MARKET SHARE
FIGURE 39 PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYERS (2019)
13.3 COMPETITIVE LEADERSHIP MAPPING
13.3.1 STARS
13.3.2 EMERGING LEADERS
13.3.3 PERVASIVE
13.3.4 EMERGING COMPANIES
FIGURE 40 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION MATRIX, 2019
13.4 COMPANY PROFILES
(Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view)
13.4.1 DARLING INGREDIENTS INC.
FIGURE 41 DARLING INGREDIENTS INC.: COMPANY SNAPSHOT (2019)
13.4.2 NITTA GELATIN INC.
FIGURE 42 NITTA GELATIN INC: COMPANY SNAPSHOT (2020)
13.4.3 TESSENDERLO GROUP
FIGURE 43 TESSENDERLO GROUP: COMPANY SNAPSHOT (2019)
13.4.4 GELITA AG
13.4.5 WEISHARDT
13.4.6 TROBAS GELATINE B.V.
13.4.7 LAPI GELATINE S.P.A
13.4.8 INDIA GELATINE & CHEMICALS LTD.
FIGURE 44 INDIA GELATINE & CHEMICALS LTD.: COMPANY SNAPSHOT (2020)
13.4.9 GELNEX INDUSTRIA E COMERCIO LTDA
13.4.10 JUNCA GELATINES SL
13.4.11 ITALGELATINE S.P.A.
13.4.12 XIAMEN GELKEN GELATIN CO. LTD.
13.4.13 GELCO INTERNATIONAL
13.4.14 HENAN BOOM GELATIN CO. LTD.
13.4.15 BAOTOU DONGBAO BIO-TECH CO. LTD.
FIGURE 45 BAOTOU DONGBAO BIO-TECH CO. LTD: COMPANY SNAPSHOT (2019)
13.4.16 ASPIRE PHARMACEUTICALS
13.4.17 NORLAND PRODUCTS, INC.
13.4.18 GELTECH CO. LTD.
13.4.19 GELIKO LLC
13.4.20 KENNEY & ROSS LIMITED
*Details on Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 186)
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
Secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the pharmaceutical gelatin market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the pharmaceutical gelatin market. The primary sources from the demand side included industry experts, procurement and purchase managers in pharmaceutical companies and gelatin capsule and tablet manufacturing companies.
Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by application, by source, by function, by type and by region).
Data Triangulation
After arriving at the market size, the total pharmaceutical gelatin market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, analyze, and forecast the size of the pharmaceutical gelatin market on the basis of application, source, function, type, and region
- To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To forecast the size of the market segments with respect to North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze competitive developments such as product launches, expansions, acquisitions, agreements, and other developments in the market
- To benchmark players within the pharmaceutical gelatin market using the Competitive Leadership Mapping framework which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific pharmaceutical gelatin market into South Korea, Australia, New Zealand, and other countries
- Further breakdown of the Latin American pharmaceutical gelatin market into Brazil, Mexico, and other countries
Get in-depth analysis of the COVID-19 impact on the Pharmaceutical Gelatin Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Pharmaceutical Gelatin Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Gelatin Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Pharmaceutical Gelatin Market